Granules India will host a webinar with IIFL Capital on September 29, 2026, at 4:30 pm IST to discuss its corporate transformation journey.

The session aims to provide insights into the company's strategic pivot beyond legacy generics. Formulations now account for approximately 75% of revenue, marking a significant shift from the legacy-5 portfolio which has reduced to under 50% of revenue in FY26 from roughly 85% in FY23.

Strategic growth engines

The company identified five key pillars driving its next phase of growth:

• Controlled substances: Focus on sustaining momentum in a regulated market with structural barriers like DEA quotas.
• Complex formulations & injectables: Roadmap for complex products to reshape portfolio and margins.
• Oncology: Monetisation of existing gross block and product pipeline, including potential 180-day exclusivity opportunities from FY28.
• FTF opportunities: Assessment of first-to-file/Para IV pipeline size and quality.
• Peptide CDMO: Building platform through Senn with a targeted $100 million revenue opportunity over the next 4-5 years.

Webinar details

The interaction will feature Granules' promoter and senior management team. Registration is open for investors seeking clarity on how the evolving business mix translates into revenue growth and margin expansion over the next 3-5 years.

Granules India Limited promoter group member Uma Devi Chigurupati acquired 2,48,80,342 equity shares via the open market on September 16, 2026. This transaction increased her direct shareholding in the pharmaceutical company by 9.12%.

The acquisition was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Prior to this purchase, Chigurupati held 92,40,761 shares, representing 3.81% of the total voting capital. The recent buy has significantly expanded her stake in the Hyderabad-based firm.

Shareholding details

The following table outlines the change in ownership structure resulting from the open market transaction:

Chigurupati’s post-acquisition holding stands at 3,41,21,103 shares, constituting 12.51% of the company’s total diluted share capital. The disclosure confirms that the acquirer belongs to the Promoter Group and that no warrants or convertible securities were involved in this specific transaction.

What the Numbers Show

The single-day acquisition of over 2.48 crore shares represents a substantial consolidation of promoter control. By moving from a 3.81% holding to 12.51%, the promoter group has nearly quadrupled its individual stake in one transaction. This aggressive accumulation via the open market, rather than through preferential allotment or rights issues, signals strong confidence in the company's valuation and future prospects among key stakeholders.